Amgen Financials
AMGN Stock  USD 333.99 1.54 0.46% 
Current Value  Last Year  Change From Last Year  10 Year Trend  

Net Profit Margin  0.18  0.2383 

 
Return On Assets  0.12  0.0691 

 
Return On Equity  1.13  1.0778 

 
Debt Equity Ratio  10.89  10.3679 

 
Current Ratio  1.57  1.6492 


Investors should never underestimate Amgen's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Amgen's cash flow, debt, and profitability to make informed and accurate decisions about investing in Amgen Inc.
Net Income 

Amgen  Select Account or Indicator 
Understanding current and past Amgen Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Amgen's financial statements are interrelated, with each one affecting the others. For example, an increase in Amgen's assets may result in an increase in income on the income statement.
Amgen Earnings Geography
Amgen Stock Summary
Amgen competes with Pharvaris, Champions Oncology, and Rezolute. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 24200 people.Foreign Associate  Mexico 
Specialization  Health Care, Pharmaceuticals, Biotechnology & Life Sciences 
Instrument  USA Stock View All 
Exchange  NASDAQ Exchange 
ISIN  US0311621009 
CUSIP  031162100 
Location  California; U.S.A 
Business Address  One Amgen Center 
Sector  Biotechnology 
Industry  Health Care 
Benchmark  Dow Jones Industrial 
Website  www.amgen.com 
Phone  805 447 1000 
Currency  USD  US Dollar 
Amgen Key Financial Ratios
Amgen's financial ratios allow both analysts and investors to convert raw data from Amgen's financial statements into concise, actionable information that can be used to evaluate the performance of Amgen over time and compare it to other companies across industries.Return On Equity  0.73  
Profit Margin  0.13 %  
Operating Margin  0.13 %  
Price To Sales  6.07 X  
Revenue  28.19 B 
Amgen Key Balance Sheet Accounts
2019  2020  2021  2022  2023  2024 (projected)  
Total Assets  59.7B  62.9B  61.2B  65.1B  97.2B  102.0B  
Other Current Liab  8.5B  10.1B  10.7B  12.5B  15.4B  16.1B  
Net Debt  23.9B  26.7B  25.3B  31.3B  53.7B  56.4B  
Retained Earnings  (21.3B)  (21.4B)  (24.6B)  (28.6B)  (26.5B)  (25.2B)  
Cash  6.0B  6.3B  8.0B  7.6B  10.9B  11.5B  
Net Receivables  4.1B  4.5B  4.9B  5.6B  7.9B  8.3B  
Other Current Assets  1.9B  2.1B  2.4B  2.4B  281M  267.0M  
Total Liab  50.0B  53.5B  54.5B  61.5B  90.9B  95.5B  
Total Current Assets  18.4B  21.1B  19.4B  22.2B  30.3B  15.2B  
Short Term Debt  3.0B  91M  87M  1.6B  1.4B  1.0B  
Inventory  3.6B  3.9B  4.1B  4.9B  9.5B  10.0B  
Accounts Payable  1.4B  1.4B  1.4B  1.6B  1.6B  1.7B  
Capital Stock  31.5B  31.8B  32.1B  32.5B  33.1B  27.5B  
Common Stock  31.5B  31.8B  32.1B  32.5B  33.1B  27.5B  
Other Assets  955M  1.3B  6.5B  2.2B  2.5B  1.4B  
Long Term Debt  27.0B  32.9B  33.2B  37.4B  63.2B  66.3B  
Good Will  14.7B  14.7B  14.9B  15.5B  18.6B  14.4B  
Intangible Assets  19.4B  16.6B  15.2B  16.1B  32.6B  34.3B  
Other Liab  9.9B  9.0B  9.1B  7.9B  9.1B  5.1B  
Net Tangible Assets  (24.4B)  (21.9B)  (23.4B)  (27.9B)  (25.2B)  (23.9B)  
Long Term Debt Total  27.0B  32.9B  33.2B  37.4B  43.0B  29.9B 
Amgen Key Income Statement Accounts
2019  2020  2021  2022  2023  2024 (projected)  
Interest Expense  1.3B  1.3B  1.2B  1.4B  2.9B  3.0B  
Total Revenue  23.4B  25.4B  26.0B  26.3B  28.2B  29.6B  
Gross Profit  19.0B  19.3B  19.5B  19.9B  19.7B  20.7B  
Operating Income  9.7B  5.8B  6.0B  5.3B  7.9B  4.1B  
Ebit  9.7B  5.8B  6.0B  5.3B  7.9B  4.3B  
Ebitda  10.4B  9.4B  9.4B  8.8B  7.9B  5.2B  
Cost Of Revenue  4.4B  6.2B  6.5B  6.4B  8.5B  8.9B  
Income Before Tax  9.1B  8.1B  6.7B  7.3B  7.9B  4.0B  
Net Income  7.8B  7.3B  5.9B  6.6B  6.7B  7.1B  
Income Tax Expense  1.3B  869M  808M  794M  1.1B  830.4M  
Research Development  4.1B  4.2B  4.8B  4.4B  4.8B  2.9B  
Tax Provision  1.3B  869M  808M  794M  1.2B  1.4B  
Interest Income  928M  674M  753M  256M  230.4M  218.9M  
Net Interest Income  (536M)  (1.0B)  (1.2B)  (1.4B)  (2.5B)  (2.3B) 
Amgen Key Cash Accounts
2019  2020  2021  2022  2023  2024 (projected)  
Change To Inventory  (66M)  (215M)  (165M)  (742M)  491M  515.6M  
Change In Cash  (908M)  229M  1.7B  (360M)  3.3B  3.5B  
Free Cash Flow  8.5B  9.9B  8.4B  8.8B  7.4B  4.5B  
Depreciation  2.2B  3.6B  3.4B  3.4B  4.1B  4.3B  
Other Non Cash Items  (186M)  (195M)  1.3B  1.3B  (991M)  (941.5M)  
Capital Expenditures  618M  608M  880M  936M  1.1B  663.6M  
Net Income  7.8B  7.3B  5.9B  6.6B  6.7B  3.4B  
End Period Cash Flow  6.0B  6.3B  8.0B  7.6B  10.9B  11.5B  
Change To Netincome  205M  (152M)  3.4B  485M  557.8M  379.4M  
Investments  20.0B  (4.7B)  733M  (6.0B)  (2.6B)  (2.5B)  
Change Receivables  (504M)  (427M)  (429M)  (746M)  (671.4M)  (637.8M)  
Net Borrowings  (4.5B)  2.5B  795M  6.6B  6.0B  6.3B  
Dividends Paid  3.5B  3.8B  4.0B  4.2B  4.6B  2.9B 
Amgen Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Amgen's current stock value. Our valuation model uses many indicators to compare Amgen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amgen competition to find correlations between indicators driving Amgen's intrinsic value. More Info.Amgen Inc is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.07 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Amgen Inc is roughly 14.87 . At this time, Amgen's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the pricetoearnings (P/E), pricetobook (P/B), pricetosales (P/S), pricetocash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amgen's earnings, one of the primary drivers of an investment's value.Amgen's Earnings Breakdown by Geography
Amgen Inc Systematic Risk
Amgen's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a welldiversified portfolio. Amgen volatility which cannot be eliminated through diversification, requires returns over the riskfree rate. Over the long run, a welldiversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a tradeoff between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twentyeight with a total number of output elements of thirtythree. The Beta measures systematic risk based on how returns on Amgen Inc correlated with the market. If Beta is less than 0 Amgen generally moves in the opposite direction as compared to the market. If Amgen Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Amgen Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Amgen is generally in the same direction as the market. If Beta > 1 Amgen moves generally in the same direction as, but more than the movement of the benchmark.
Amgen Thematic Clasifications
Amgen Inc is part of several thematic ideas from Health Management to Drugs. If you are a themeoriented, socially responsible, and at the same time, a resultdriven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasHealth Management  View  
Drugs  View  
Macroaxis Index  View  
Cash Cows  View  
Robots And Drones  View  
Giant Impact  View  
Baby Boomer Prospects  View 
Today, most investors in Amgen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Amgen's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Amgen growth as a starting point in their analysis.
Price Earnings To Growth Ratio 

Amgen August 4, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Amgen help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Amgen Inc. We use our internallydeveloped statistical techniques to arrive at the intrinsic value of Amgen Inc based on widely used predictive technical indicators. In general, we focus on analyzing Amgen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Amgen's daily price indicators and compare them against related drivers.
Downside Deviation  1.15  
Information Ratio  0.1352  
Maximum Drawdown  15.61  
Value At Risk  (1.73)  
Potential Upside  2.33 
Additional Information and Resources on Investing in Amgen Stock
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a wellinformed decision on Amgen Inc Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.52)  Dividend Share 8.64  Earnings Share 7.01  Revenue Per Share 55.148  Quarterly Revenue Growth 0.22 
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.